Novel 1-alkyl-substituted 1,4-dihydropyridinelactone anti-diabet

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546116, A61K 31435, C07D491048

Patent

active

050267140

ABSTRACT:
Novel blood sugar-lowering dihydropyridinelactones of the formula ##STR1## in which R represents halogen, C.sub.1 -C.sub.10 -alkyl, C.sub.1 -C.sub.10 -alkoxy, C.sub.1 -C.sub.10 -alkylthio, C.sub.1 -C.sub.10 -alkylsulphinyl, C.sub.1 -C.sub.10 -alkylsulphonyl, cyano, C.sub.1 -C.sub.6 - mono- or polyfluoroalkyl, C.sub.1 -C.sub.6 -mono- or polyfluoroalkoxy or nitro,

REFERENCES:
patent: 4048171 (1977-09-01), Bossert et al.
patent: 4145432 (1979-03-01), Sato
patent: 4253248 (1985-07-01), Franckowiak et al.
Schramm et al., Nature vol. 303, Jun. 9, 1983.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Novel 1-alkyl-substituted 1,4-dihydropyridinelactone anti-diabet does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel 1-alkyl-substituted 1,4-dihydropyridinelactone anti-diabet, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel 1-alkyl-substituted 1,4-dihydropyridinelactone anti-diabet will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1040106

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.